Skip to main content


Page 26 of 29

  1. Specific immunotherapy is the only treatment able to act on the causes and not only on the symptoms of respiratory allergy. Sublingual immunotherapy (SLIT) was introduced as an option to subcutaneous immunothe...

    Authors: Cristoforo Incorvaia, Simonetta Masieri, Patrizia Berto, Silvia Scurati and Franco Frati
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:29
  2. Authors: Oxana Latycheva, Christine Hampson, Mark Greenwald, Sabrina Panetta and Rupinder Chera
    Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P32

    This article is part of a Supplement: Volume 6 Supplement 2

  3. Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of ...

    Authors: Serena E O'Neil, Carina Malmhäll, Konstantinos Samitas, Teet Pullerits, Apostolos Bossios and Jan Lötvall
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:28
  4. Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with puri...

    Authors: Luis Prieto, Ricardo Palacios, Dulce Aldana, Anna Ferrer, Carmen Perez-Frances, Victoria Lopez and Rocio Rojas
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:27
  5. Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Syste...

    Authors: Jennifer J Huang, Jae Won Joh, Judy Fuentebella, Anup Patel, Tammie Nguyen, Scott Seki, Lisa Hoyte, Neha Reshamwala, Christine Nguyen, Anthony Quiros, Dorsey Bass, Eric Sibley, William Berquist, Kenneth Cox, John Kerner and Kari C Nadeau
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:25
  6. Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...

    Authors: Hilary J Longhurst, Henriette Farkas, Timothy Craig, Emel Aygören-Pürsün, Claire Bethune, Janne Bjorkander, Konrad Bork, Laurence Bouillet, Henrik Boysen, Anette Bygum, Teresa Caballero, Marco Cicardi, John Dempster, Mark Gompels, Jimmy Gooi, Sofia Grigoriadou…
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:22
  7. Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.

    Authors: Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Eva Rusicke, Thomas Klingebiel and Wolfhart Kreuz
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:21
  8. C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadi...

    Authors: Tom Bowen, John Brosz, Kristylea Brosz, Jacques Hebert and Bruce Ritchie
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:20
  9. Women with hereditary angioedema (HAE) are more likely to be symptomatic that men. Hormonal factors (puberty, contraception, pregnancy,....) play a significant role in the precipitation or worsening of the con...

    Authors: Laurence Bouillet
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:17
  10. Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released ...

    Authors: Marco Cicardi and Andrea Zanichelli
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:14

The official journal of CSACI

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.5
    Source Normalized Impact per Paper (SNIP): 0.904
    SCImago Journal Rank (SJR): 0.749

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 140

    Usage 2023
    Downloads: 1,545,686
    Altmetric mentions: 2,123